<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 對照品 > 中藥對照品 >
    3,17-Diiodoandrosta-3,5,16-triene
    產(chǎn)品基本信息
    產(chǎn)品編號:D126860
    產(chǎn)品名稱:3,17-Diiodoandrosta-3,5,16-triene
    產(chǎn)品CAS:1268610-38-3
    規(guī)格含量:25mg
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號: D126860
    名稱: 3,17-Diiodoandrosta-3,5,16-triene
    別名: (8R,9S,10R,13S,14S)-3,17-Diiodo-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthrene; 3,17-Diiodo-androst-3,5,16-triene
    CAS號: 1268610-38-3
    分子式: C??H??I?
    分子量: 506.2
    種類: Standards; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: 3,17-Diiodoandrosta-3,5,16-triene is used in the synthesis of 3,17-Dicarboxamido-androst-3,5,16-triene via palladium-catalyzed aminocarbonylation. It is an Abiraterone 3-iodine impurity. Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
    參考文獻(xiàn)


    2011-2018 信陽萊耀生物科技有限公司 @ 信陽埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      亚洲成人一区二区三区 | 一级A片黄女人高潮网站 | 影音先锋国产在线 | poronovideos性寡妇 | 国产女主播视频一区二区 |